ClinicalTrialsFinder

RecruitingNCT06170177

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Bladder Archive: Observational Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Sponsor

IRCCS San Raffaele

Enrollment

4,000 participants

Start Date

Feb 4, 2013

Study Type

OBSERVATIONAL

Conditions

Muscle-Invasive Bladder Carcinoma Bladder Cancer Muscle Invasive Bladder Urothelial Carcinoma Progression, Disease Radical Cystectomy Bladder Cancer TNM Staging Bladder Cancer Stage IIa Bladder Cancer Stage IIb Bladder Cancer Stage IV Bladder Leiomyosarcoma Bladder Cancer Stage II Bladder Cancer Stage IIIa Bladder Cancer Stage IIIb Bladder Cancer Stage IIIc Bladder Urothelial Carcinoma Urinary Diversion Neobladder

Summary

Observational study on the quality of life and pathological state of patients underwent radical cystectomy.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

subjects underwent radical cystectomy
\> 18 years old
Ability to read and sign the informed consent

Exclusion Criteria2

Age \<18 years
Inability to read and sign the informed consent

Interventions

PROCEDURERadical Cystectomy

A radical cystectomy is an operation to remove the whole bladder

Locations(1)

IRCCS Ospedale San Raffaele

Milan, MI, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT06170177

Related Trials

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

NCT07061964123 locations

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

NCT05987241491 locations

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

NCT000268841 location

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

NCT0712999379 locations

Bio Clinical Collection of Urothelial Carcinoma

NCT049704721 location